Stockreport

Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature

Gen Digital Inc.  (GEN) 
Last gen digital inc. earnings: 3/16 04:30 pm Check Earnings Report
US:NYSE Investor Relations: genesishcc.com/investor-relations
PDF $13 Million Series A Financing from Medicxi Development pipeline based on co-founders’ research into disconnecting tumour cell networksInitial focus on glioblastoma, exp [Read more]